Angen Liu

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

Cancer therapy in the necroptosis era

Microsatellite Instability in Colorectal Cancer

Cathepsin B as a cancer target

Sphingolipid metabolism in cancer signalling and therapy

A guide to immunometabolism for immunologists

Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond

Targeting Ferroptosis to Iron Out Cancer

Sphingolipids and their metabolism in physiology and disease

Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities

Necroptosis: A new way of dying?

Milestones of Lynch syndrome: 1895–2015

Activation of apoptosis signalling pathways by reactive oxygen species

Sphingolipid metabolites in inflammatory disease

Peripheral Blood Mononuclear Phagocytes From Patients With Chronic Periodontitis Are Primed for Osteoclast Formation

Therapeutic exploitation of necroptosis for cancer therapy

Ceramide induced mitophagy and tumor suppression

Exosomes

Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Extracellular Hsp90 mediates an NF‐κB dependent inflammatory stromal program: Implications for the prostate tumor microenvironment

Natural product and natural product derived drugs in clinical trials

Over-expression of low-density lipoprotein receptor-related Protein-1 is associated with poor prognosis and invasion in pancreatic ductal adenocarcinoma

The mismatch repair‐mediated cell cycle checkpoint response to fluorodeoxyuridine

Silencing Mitogen-Activated Protein Kinase-Activated Protein Kinase-2 Arrests Inflammatory Bone Loss

Acid ceramidase‐mediated production of sphingosine 1‐phosphate promotes prostate cancer invasion through upregulation of cathepsin B

A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion

Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis